Skip to content

Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease

Prognostic Impact of Lesion-specific Hemodynamic Index and Disease Characteristics in Patients With Coronary Artery Disease Assessed by Fractional Flow Reserve

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05250557
Acronym
PRIME-FFR
Enrollment
2429
Registered
2022-02-22
Start date
2021-08-01
Completion date
2026-12-31
Last updated
2022-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.

Detailed description

Fractional flow reserve (FFR)-based revascularization is the currently best practice recommended by guidelines. In addition to the use of coronary physiological indices as a vessel-specific metric, recent studies suggested the clinical importance of local hemodynamics in prediction of risk for target vessel failure or acute coronary syndrome in patients with coronary artery disease. In patients who receive percutaneous coronary intervention (PCI), the absolute value and pattern of FFR change after stenting are helpful in defining the additional target for PCI and risk stratification after PCI. However, there has been no prospective study that proved the benefit of change in FFR across the lesion (ΔFFR) in daily clinical practice, and FFR usage after stenting is much less than before stenting. Accordingly, we will prove the benefit of ΔFFR in addition to FFR, prognostic implications of combining RFR and FFR, and the comprehensive risk model with post-PCI FFR, clinical and disease characteristics in a prospective study, to maximize the benefit of invasive physiologic assessment.

Interventions

DIAGNOSTIC_TESTFractional flow reserve

Physiologic assessment includes Δ FFR (lesion-specific) and FFR (vessel-specific) measurement. Δ FFR is defined as a pressure step up across the lesion. Coronary angiography and physiologic assessment will be analyzed by an independent core laboratory (Seoul National University Hospital, Clinical Trial Center, Seoul, South Korea).

Sponsors

Keimyung University Dongsan Medical Center
CollaboratorOTHER
Inje University
CollaboratorOTHER
Ulsan University Hospital
CollaboratorOTHER
Dong-A University Hospital
CollaboratorOTHER
Gyeongsang National University Hospital
CollaboratorOTHER
KangWon National University Hospital
CollaboratorOTHER
Wonju Severance Christian Hospital
CollaboratorOTHER
Severance Hospital
CollaboratorOTHER
Seoul National University Bundang Hospital
CollaboratorOTHER
Tsuchiura Kyodo General Hospital
CollaboratorOTHER
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥20 years 2. All comers who underwent successful FFR measurement and pullback tracing

Exclusion criteria

1. Chronic renal failure (estimated glomerular filtration rate \<30) 2. ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history 3. Primary myocardial or valvular disease 4. Left ventricular ejection fraction \< 30% 5. Hemodynamically unstable clinical conditions 6. Life expectancy \< 2 years

Design outcomes

Primary

MeasureTime frameDescription
Adverse cardiovascular event according to ΔFFR (Deferral of PCI group)Upto 2 years after index procedureComposite of 2-year target vessel revascularization, target vessel myocardial infarction, and cardiac death
Adverse cardiovascular event according to post-PCI FFR (PCI group)Upto 2 years after index procedureComposite of 2-year target vessel revascularization, target vessel myocardial infarction, and cardiac death

Countries

South Korea

Contacts

Primary ContactBon-Kwon Koo, MD, PhD
bkkoo@snu.ac.kr+82-2-2072-2062
Backup ContactSeokhun Yang, MD
newturnz7@gmail.com+82-2-2072-2062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026